Cargando…
Reteplase versus Streptokinase in Management of ST-segment Elevation Myocardial Infarction; a Letter to the Editor
Autores principales: | Giahchi, Fahimeh, Mohammadi, Mahmonir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789073/ https://www.ncbi.nlm.nih.gov/pubmed/31633089 http://dx.doi.org/10.22114/ajem.v0i0.143 |
Ejemplares similares
-
Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen
por: Bendary, Ahmed, et al.
Publicado: (2017) -
Preintensive care: Thrombolytic (streptokinase or tenecteplase) in ST elevated acute myocardial infarction at peripheral hospital
por: Bawaskar, Himmatrao S., et al.
Publicado: (2019) -
The Streptokinase Therapy Complications and its Associated Risk Factors in Patients with Acute ST Elevation Myocardial Infarction
por: Aslanabadi, Naser, et al.
Publicado: (2018) -
Reply to letter to the editor: Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Li, Yi-Heng, et al.
Publicado: (2021) -
Leucocytoclastic vasculitis: A complication after streptokinase therapy for acute myocardial infarction
por: Makkar, Manisha, et al.
Publicado: (2013)